UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 54

Sortiert nach

HER2 Low Breast Cancer: A New Subtype or a Trojan for Cytotoxic Drug Delivery?

International journal of molecular sciences, 2023-05, Vol.24 (9), p.8206

2023

Link zum Volltext

Verfügbarkeit prüfen

Beliefs about medicines’ association with endocrine therapy adherence in early breast cancer survivors in Croatia

Acta Pharmaceutica, 2023-12, Vol.73 (4), p.673-689

2023

Link zum Volltext

Verfügbarkeit prüfen

A first report of a rare TP53 variant associated with Li-Fraumeni syndrome manifesting as invasive breast cancer and malignant solitary fibrous tumor

World journal of surgical oncology, 2021-08, Vol.19 (1), p.1-254, Article 254

2021

Link zum Volltext

Verfügbarkeit prüfen

Exploring adherence in patients with advanced breast cancer: focus on CDK4/6 inhibitors

Acta Pharmaceutica, 2023-12, Vol.73 (4), p.633-654

2023

Link zum Volltext

Verfügbarkeit prüfen

The role of interleukin‑7 serum level as biological marker in breast cancer: a cross‑sectional, observational, and analytical study

World journal of surgical oncology, 2022-07, Vol.20 (1), p.1-225, Article 225

2022

Link zum Volltext

Verfügbarkeit prüfen

Interleukin 17 in early invasive breast cancer

Frontiers in oncology, 2023-06, Vol.13, p.1171254-1171254

2023

Link zum Volltext

Verfügbarkeit prüfen

Effects of trastuzumab and trastuzumab emtansine on corrected QT interval and left ventricular ejection fraction in patients with metastatic (HER2+) breast cancer

The Egyptian heart journal, 2023-02, Vol.75 (1), p.11-11, Article 11

2023

Link zum Volltext

Verfügbarkeit prüfen

PROGNOSTIC VALUE OF TOPOISOMERASE 2-ALPHA AND B-MYB IN EARLY BREAST CANCER TREATED WITH ADJUVANT CHEMOTHERAPY

Acta clinica Croatica (Tisak), 2021-03, Vol.60 (1), p.16-24

2021

Link zum Volltext

Verfügbarkeit prüfen

Pneumonitis as a side effect of breast cancer treatment: T-DXd and/or SBRT?

Liječnički vjesnik, 2023-04, Vol.145 (Supp 2), p.78-78

2023

Link zum Volltext

Verfügbarkeit prüfen

Sirtuins in tumorigenesis

Periodicum biologorum, 2014-12, Vol.116 (4), p.381

2014

Link zum Volltext

Verfügbarkeit prüfen

Smjernice Hrvatskoga onkološkog društva za dijagnozu, liječenje i praćenje bolesnica/ka oboljelih od invazivnog raka dojke (HOD RD-3)

Liječnički vjesnik, 2022-10, Vol.144 (9-10), p.295

2022

Link zum Volltext

Verfügbarkeit prüfen

RACIONALNA PRIMJENA SERUMSKIH TUMORSKIH BILJEGA U DIJAGNOSTICI I LIJEČENJU SOLIDNIH TUMORA

Liječnički vjesnik, 2016-05, Vol.138 (3-4)

2016

Link zum Volltext

Verfügbarkeit prüfen

SMJERNICE ZA PROVOĐENJE DIJAGNOSTIČKIH PRETRAGA PRIJE POČETKA LIJEČENJA ONKOLOŠKOG BOLESNIKA – KLINIČKE PREPORUKE HRVATSKOG DRUŠTVA ZA INTERNISTIČKU ONKOLOGIJU HLZ-a II. dio: rak dojke, ginekološki tumori (rak jajnika, rak tijela maternice, rak vrata maternice), rak pluća, maligni melanom, sarkomi, tumori središnjega živčanog sustava, rak glave i vrata

Liječnički vjesnik, 2018-06, Vol.140 (3-4)

2018

Link zum Volltext

Verfügbarkeit prüfen

SMJERNICE ZA PROVOĐENJE DIJAGNOSTIČKIH PRETRAGA PRIJE POČETKA LIJEČENJA ONKOLOŠKOG BOLESNIKA – KLINIČKE PREPORUKE HRVATSKOG DRUŠTVA ZA INTERNISTIČKU ONKOLOGIJU HLZ-a I. dio: tumori urogenitalnog sustava (rak bubrega, rak mokraćnog mjehura, rak prostate, rak testisa), tumori probavnog sustava (rak jednjaka, rak želuca, rak debelog i završnog crijeva, rak gušterače, rak žučnih vodova, hepatocelularni rak, neuroendokrine novotvorine)

Liječnički vjesnik, 2018-06, Vol.140 (3-4)

2018

Link zum Volltext

Verfügbarkeit prüfen

The Challenges and Opportunities of the Implementation of Comprehensive Genomic Profiling in Everyday Clinical Practice with Non-Small Cell Lung Cancer: National Results from Croatia

Cancers, 2023-06, Vol.15 (13), p.3395

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract P4-01-39: Real-world efficaccy of dual antiHER2 therapy in first line metastatic HER2-positive breast cancer and the possibility of prediction of long-term response

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P4-P4-01-39

2023

Link zum Volltext

Verfügbarkeit prüfen

Pneumonitis as a side effect of breast cancer treatment: T-DXd and/or SBRT?

Liječnički vjesnik, 2023-01, Vol.145 (Supp 2), p.78-78

2023

Link zum Volltext

Verfügbarkeit prüfen

Fatal outcome of posterior "reversible" encephalopathy syndrome in metastatic colorectal carcinoma after irinotecan and fluoropyrimidine chemotherapy regimen

World journal of surgical oncology, 2014-08, Vol.12 (1), p.264

2014

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Value of Topoisomerase 2-Alpha and B-Myb in Early Breast Cancer Treated with Adjuvant Chemotherapy

Acta clinica Croatica (Tisak), 2021-01, Vol.60. (1.), p.16-24

2021

Link zum Volltext

Verfügbarkeit prüfen

Hypoxia in solid tumors: biological responses to hypoxia and implications on therapy and prognosis

Periodicum biologorum, 2014-12, Vol.116 (4), p.361

2014

Link zum Volltext

Verfügbarkeit prüfen

Circulating Her-2/Neu Extracellular Domain in Breast Cancer Patients-Correlation with Prognosis and Clinicopathological Parameters Including Steroid Receptor, Her-2/Neu Receptor Coexpression

Pathology oncology research, 2015-07, Vol.21 (3), p.589-595

2015

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of proliferation markers expression in breast cancer

Medical oncology (Northwood, London, England), 2013-06, Vol.30 (2), p.523-523, Article 523

2013

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Value of Ki-67 in Breast Carcinoma: Tissue Microarray Method Versus Whole Section Analysis- Potentials and Pitfalls

Pathology oncology research, 2015-04, Vol.21 (2), p.315-324

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(52)
Webseiten
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

HER2 Low Breast Cancer: A New Subtype or a Trojan for Cytotoxic Drug Delivery?

Beliefs about medicines’ association with endocrine therapy adherence in early breast cancer survivors in Croatia

A first report of a rare TP53 variant associated with Li-Fraumeni syndrome manifesting as invasive breast cancer and malignant solitary fibrous tumor

Exploring adherence in patients with advanced breast cancer: focus on CDK4/6 inhibitors

The role of interleukin‑7 serum level as biological marker in breast cancer: a cross‑sectional, observational, and analytical study

Interleukin 17 in early invasive breast cancer

Effects of trastuzumab and trastuzumab emtansine on corrected QT interval and left ventricular ejection fraction in patients with metastatic (HER2+) breast cancer

PROGNOSTIC VALUE OF TOPOISOMERASE 2-ALPHA AND B-MYB IN EARLY BREAST CANCER TREATED WITH ADJUVANT CHEMOTHERAPY

Synthesis of Recommendations From 25 Countries and 31 Oncology Societies: How to Navigate Through Covid-19 Labyrinth

Pneumonitis as a side effect of breast cancer treatment: T-DXd and/or SBRT?

Sirtuins in tumorigenesis

Smjernice Hrvatskoga onkološkog društva za dijagnozu, liječenje i praćenje bolesnica/ka oboljelih od invazivnog raka dojke (HOD RD-3)

RACIONALNA PRIMJENA SERUMSKIH TUMORSKIH BILJEGA U DIJAGNOSTICI I LIJEČENJU SOLIDNIH TUMORA

The Challenges and Opportunities of the Implementation of Comprehensive Genomic Profiling in Everyday Clinical Practice with Non-Small Cell Lung Cancer: National Results from Croatia

Next-Generation Sequencing of Circulating Tumor DNA Can Optimize Second-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer after Progression on anti-EGFR Therapy: Time to Rethink Our Approach

Abstract P4-01-39: Real-world efficaccy of dual antiHER2 therapy in first line metastatic HER2-positive breast cancer and the possibility of prediction of long-term response

Pneumonitis as a side effect of breast cancer treatment: T-DXd and/or SBRT?

Fatal outcome of posterior "reversible" encephalopathy syndrome in metastatic colorectal carcinoma after irinotecan and fluoropyrimidine chemotherapy regimen

Prognostic Value of Topoisomerase 2-Alpha and B-Myb in Early Breast Cancer Treated with Adjuvant Chemotherapy

Hypoxia in solid tumors: biological responses to hypoxia and implications on therapy and prognosis

Circulating Her-2/Neu Extracellular Domain in Breast Cancer Patients-Correlation with Prognosis and Clinicopathological Parameters Including Steroid Receptor, Her-2/Neu Receptor Coexpression

Prognostic value of proliferation markers expression in breast cancer

Prognostic Value of Ki-67 in Breast Carcinoma: Tissue Microarray Method Versus Whole Section Analysis- Potentials and Pitfalls

Suchergebnisse filtern